Evidence map›Paper›PMID 39926961›Full record

ArticleJournal of pharmacy & bioallied sciences2024

Assessment of the Antimicrobial Efficacy and Mechanical Properties of Glass Ionomer Cement (GIC) Incorporating Silver Nanoparticles In Varying Concentrations for Pediatric Dental Applications.

Md Imran, Rashmirekha Mallick, Rohit Vadlamani, Antarik Dhar

Abstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Md ImranDepartment of Dentistry, Patna Medical College and Hospital, Patna, Bihar, India.
Rashmirekha MallickDepartment of Conservative Dentistry and Endodontics, SCB Dental College and Hospital, Cuttack, Odisha, India.
Rohit VadlamaniBDS, MS, DDS, Research Scholar and General Dentist, University of Louisville School of Dentistry, Louisville, Kentucky, USA, University of Louisville School of Dentistry, Louisville, Kentucky, USA.
Antarik DharDepartment of Pedodontics, Awadh Dental College and Hospital, East Singhbhum, Jamshedpur, Jharkhand, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glass ionomer cement (GIC) is widely used in pediatric dentistry due to its fluoride-releasing properties and strong adhesion to tooth structure. However, enhancing its antimicrobial efficacy remains a challenge. Incorporating silver nanoparticles (AgNPs) has been proposed as a solution to increase the antimicrobial properties of GIC without compromising its mechanical strength. Materials and Methods: This study investigated the effects of integrating varying concentrations of AgNPs into GIC on its antimicrobial efficacy against common oral pathogens and its mechanical properties. Three concentrations of AgNPs (0.5%, 1%, and 1.5% by weight) were evaluated. Antimicrobial activity was assessed using the agar diffusion test against Results: The GIC modified with 1% AgNPs demonstrated optimal antimicrobial activity, showing a significant inhibition zone increase of 25% against Conclusion: The addition of 1% AgNPs to GIC significantly enhances its antimicrobial properties without adversely affecting its mechanical strength. This formulation holds potential for improving the effectiveness of pediatric dental restorations by reducing the risk of secondary caries.

Indexed as

Antimicrobial efficacyglass ionomer cementmechanical propertiespediatric dentistrysilver nanoparticles

Identifiers

PMID39926961
PMCPMC11805101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.